Our Thinking

Emerging Healthcare Landscape of India

  23 November, 2017

Read more

The healthcare landscape of emerging India is rapidly evolving and transforming. Adaptation by market participants is critical for growth.

Reluctantly Redundant – The Real Cost of Power

  11 December, 2010

India is burdened with a substantial power deficit resulting in vast tracts of the country, living in the dark shadows of frequent power outages. Meanwhile, India’s hapless citizens have already invested around Rs 100,000 crores in power back-up equipment due to the poor reliability of grid power. Unless the government and regulators craft solutions that address the specific power needs of different segments of society, we will all have no option but to invest in and maintain a high-level of power redundancy.

Navigating the Minefield – How to make your Outsourcing Initiative a Success

  17 April, 2002   

Outsourcing has been labeled as one of the most important management ideas of the last five to seven decades. Organisations have been outsourcing activities, however, for many years. Indian companies are just waking up to outsourcing. Carefully navigating the potential minefield that presents itself in every outsourcing relationship, will help your company to make your outsourcing initiative a success.

Accountability: Angst, Awareness, Action

  15 March, 2012

India is poised at a crucial juncture in its post-independence history. Accountability, the heartbeat of governance, is under siege. The epidemic of unaccountability lurks beneath India’s myriad tragedies, conquering the spirit of the citizen and con-straining India from unlocking its full economic and social potential.

The Future of Indian Biosimilars

  29 September, 2009  

The evolutionary pressure to merge the boundaries between pharmaceutical and biotechnology companies in order to survive, is increasing. The current view on the Indian biosimilars industry is that at some point in the near future, it will replicate the relative success of the Indian pharma generics industry, in the global markets. The reality may turn out to be quite different. A deep chasm lies ahead for Indian biosimilar manufacturers. The path they seek to travel will reveal the biggest hurdles they are ever likely to face. This journey, executed with strategic foresight and meticulous planning, however, could lead to a bloom they can fully harvest.

Saving Lives – The Promise of Point of Care Testing

  7 July, 2011   

The past few years have heralded much excitement around the uses of Point of Care Testing (PoCT). With advancements in electronics, the miniaturisation and digitisation of technology has spilled over into the realm of medical diagnostics. Through portable, transportable and handheld instruments, PoCT is the ability to bring the diagnostic capabilities of a laboratory to the patients’ bedsides. It is effectively a potential solution to some of the health problems that India faces, especially in the context of the heavy burden of infectious diseases that plagues it and its large rural population with limited or no access to testing facilities.

Business Landscape of India

  2 January, 2008  

India’s growth has been accelerated over the last 20 years. Major multi-national companies have entered India and capitalised on India’s human capital. This article elaborates the economic outlook, foreign trade and the market opportunities to enter the country. It also specifies India’s edge over China in context of its competitive skills and its regulatory environment.